Effects of Endothelin‐A Receptor and Angiotensin Converting Enzyme Inhibition on the Development of Progressive Proteinuria in Diabetic Dahl SS Rats with Pre‐existing Renal Disease

Renal Disease ◽

Enzyme Inhibition ◽

Converting Enzyme ◽

Endothelin A Receptor ◽

Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats

British Journal of Pharmacology ◽

10.1038/sj.bjp.0707325 ◽

2007 ◽

Vol 151 (8) ◽

pp. 1187-1197 ◽

Cited By ~ 11

Author(s):

G Wölkart ◽

X Pang ◽

H Stessel ◽

M Kirchengast ◽

F Brunner

Keyword(s):

Enzyme Inhibition ◽

Cardiac Dysfunction ◽

Diabetic Rats ◽

Converting Enzyme ◽

Receptor Antagonism ◽

Endothelin A Receptor ◽

Angiotensin-Converting Enzyme Inhibition Attenuates Proteinuria and Renal TGF-β1 mRNA Expression in Rats with Chronic Renal Disease

Pharmacology ◽

10.1159/000028222 ◽

1998 ◽

Vol 57 (1) ◽

pp. 20-27 ◽

Cited By ~ 21

Author(s):

Shujath M. Ali ◽

Nicholas J. Laping ◽

Todd A. Fredrickson ◽

Lisa C. Contino ◽

Barbara A. Olson ◽

...

Keyword(s):

Renal Disease ◽

Mrna Expression ◽

Enzyme Inhibition ◽

Chronic Renal Disease ◽

Converting Enzyme ◽

Tgf Β1

Renal Endothelin System in Diabetes: Comparison of Angiotensin-Converting Enzyme Inhibition and Endothelin-A Antagonism

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199800001-00141 ◽

1998 ◽

Vol 31 ◽

pp. S492-S495 ◽

Cited By ~ 26

Author(s):

Berthold Hocher ◽

Andreas Lun ◽

Friedrich Priem ◽

Hans-H. Neumayer ◽

Manfred Raschack

Keyword(s):

Enzyme Inhibition ◽

Converting Enzyme ◽

Endothelin System ◽

Long-Term Benefits of the Antiproteinuric Effect of Angiotensin-Converting Enzyme Inhibition in Nondiabetic Renal Disease

American Journal of Kidney Diseases ◽

10.1016/s0272-6386(12)70187-7 ◽

1993 ◽

Vol 22 (1) ◽

pp. 202-206 ◽

Cited By ~ 65

Author(s):

Ron T. Gansevoort ◽

Dick de Zeeuw ◽

Paul E. de Jong

Keyword(s):

Renal Disease ◽

Enzyme Inhibition ◽

Converting Enzyme ◽

Antiproteinuric Effect ◽

Long-Term Survival and Hemodynamics After Endothelin-A Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition in Rats With Chronic Heart Failure

Circulation ◽

10.1161/01.cir.0000027138.07524.38 ◽

2002 ◽

Vol 106 (9) ◽

pp. 1159-1164 ◽

Cited By ~ 35

Author(s):

Paul Mulder ◽

Houssaine Boujedaini ◽

Vincent Richard ◽

Jean-Paul Henry ◽

Sylvanie Renet ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Converting Enzyme ◽

Term Survival ◽

Endothelin A Receptor ◽

Role of angiotensin-converting-enzyme inhibition in patients with renal disease

American Journal of Health-System Pharmacy ◽

10.1093/ajhp/57.suppl_1.s12 ◽

2000 ◽

Vol 57 (suppl_1) ◽

pp. S12-S18 ◽

Cited By ~ 15

Author(s):

Harold J. Manley

Keyword(s):

Renal Disease ◽

Enzyme Inhibition ◽

Converting Enzyme ◽

Review: Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT1-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension

Journal of the Renin-Angiotensin-Aldosterone System ◽

10.3317/jraas.2002.022 ◽

2002 ◽

Vol 3 (2) ◽

pp. 79-89 ◽

Cited By ~ 5

Author(s):

Philip Swales ◽

Bryan Williams

Keyword(s):

Angiotensin Ii ◽

Renal Disease ◽

Calcium Channel ◽

Enzyme Inhibition ◽

Converting Enzyme ◽

Channel Blockade ◽

Calcium Channel Blockade ◽

Angiotensin converting enzyme inhibition reduces proteinuria in Nigerians with chronic renal disease

European Journal of Clinical Pharmacology ◽

10.1007/bf00315425 ◽

1990 ◽

Vol 39 (4) ◽

pp. 423-424 ◽

Cited By ~ 2

Author(s):

A. A. Ajayi ◽

A. T. Ajayi

Keyword(s):

Renal Disease ◽

Enzyme Inhibition ◽

Chronic Renal Disease ◽

Converting Enzyme ◽

Changing the course of diabetic nephropathy: angiotensin-converting enzyme inhibition in type I diabetic renal disease

Cleveland Clinic Journal of Medicine ◽

10.3949/ccjm.61.1.38 ◽

1994 ◽

Vol 61 (1) ◽

pp. 38-42 ◽

Cited By ~ 2

Author(s):

M. A. Pohl

Keyword(s):

Diabetic Nephropathy ◽

Renal Disease ◽

Enzyme Inhibition ◽

Type I ◽

Converting Enzyme ◽

Diabetic Renal Disease ◽

Endothelin A Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition Are Synergistic via an Endothelin B Receptor-Mediated and Nitric Oxide-Dependent Mechanism

Journal of the American Society of Nephrology ◽

10.1097/01.asn.0000141313.84470.4b ◽

2004 ◽

Vol 15 (10) ◽

pp. 2601-2610 ◽

Cited By ~ 33

Author(s):

J. Goddard

Keyword(s):

Nitric Oxide ◽

Converting Enzyme ◽

Endothelin B Receptor ◽

Endothelin A Receptor ◽

Endothelin A ◽

Endothelin B ◽

Dependent Mechanism